Document Detail

Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant.
MedLine Citation:
PMID:  22917699     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND OBJECTIVES: Podocyte loss is key in glomerulosclerosis. Activated parietal epithelial cells are proposed to contribute to pathogenesis of glomerulosclerosis and may serve as stem cells that can transition to podocytes. CD44 is a marker for activated parietal epithelial cells. This study investigated whether activated parietal epithelial cells are increased in early recurrent FSGS in transplant compared with minimal change disease.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: CD44 staining in renal allograft biopsies from 12 patients with recurrent FSGS was performed and compared with native kidneys with minimal change disease or FSGS and normal control native and transplant kidneys without FSGS. CD44+ epithelial cells along Bowman's capsule in the parietal epithelial cell location and over the glomerular tuft in the visceral epithelial cell location were assessed.
RESULTS: Cases with early recurrent FSGS manifesting only foot process effacement showed significantly increased CD44+ visceral epithelial cells involving 29.0% versus 2.6% of glomeruli in minimal change disease and 0% in non-FSGS transplants. Parietal location CD44 positivity also was numerically increased in recurrent FSGS. In later transplant biopsies, glomeruli with segmental lesions had more CD44+ visceral epithelial cells than glomeruli without lesions.
CONCLUSIONS: Parietal epithelial cell activation marker is significantly increased in evolving FSGS versus minimal change disease, and this increase may distinguish early FSGS from minimal change disease. Whether parietal epithelial cell activation contributes to pathogenesis of sclerosis in idiopathic FSGS or is a regenerative/repair response to replace injured podocytes awaits additional study.
Huma Fatima; Marcus J Moeller; Bart Smeets; Hai-Chun Yang; Vivette D D'Agati; Charles E Alpers; Agnes B Fogo
Related Documents :
22553399 - Pro-apoptotic effects of tectorigenin on human hepatocellular carcinoma hepg2 cells.
20709739 - Podoplanin-positive cells are a hallmark of encapsulating peritoneal sclerosis.
22369729 - Localization and phototoxic effect of zinc sulfophthalocyanine photosensitizer in human...
21291899 - Progesterone signals through membrane progesterone receptors (mprs) in mda-mb-468 and m...
1821619 - Morphological and immunological heterogeneity of human ovarian neoplasms.
22573829 - Estrogen inhibits d2s receptor regulated gi3 and gs protein interactions to stimulate p...
24874479 - Genetic ablation of β-catenin inhibits the proliferative phenotype of mouse liver aden...
10975739 - Age-related decrease of the perineuronal satellite cell number in the rabbit spinal gan...
20156439 - Protection of hippocampal neurogenesis by tat-bcl-x(l) after cerebral ischemia in mice.
Publication Detail:
Type:  Journal Article; Research Support, American Recovery and Reinvestment Act; Research Support, N.I.H., Extramural     Date:  2012-08-23
Journal Detail:
Title:  Clinical journal of the American Society of Nephrology : CJASN     Volume:  7     ISSN:  1555-905X     ISO Abbreviation:  Clin J Am Soc Nephrol     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-08     Completed Date:  2013-06-21     Revised Date:  2013-11-14    
Medline Journal Info:
Nlm Unique ID:  101271570     Medline TA:  Clin J Am Soc Nephrol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1852-8     Citation Subset:  IM    
Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens, CD44 / analysis
Child, Preschool
Dystroglycans / analysis
Epithelial Cells / pathology*
Glomerulosclerosis, Focal Segmental / diagnosis,  etiology*
Kidney Transplantation*
Middle Aged
Nephrosis, Lipoid / diagnosis
Podocytes / pathology
Urothelium / pathology*
Grant Support
Reg. No./Substance:
0/Antigens, CD44; 0/CD44 protein, human; 0/DAG1 protein, human; 146888-27-9/Dystroglycans

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Obstetric Nephrology: Pregnancy in Women with Diabetic Nephropathy--The Role of Antihypertensive Tre...
Next Document:  Association of smoking with cardiovascular and infection-related morbidity and mortality in chronic ...